OncoMed Pharmaceuticals, Inc. EPS - Earnings per Share 2013-2018 | OMED
OncoMed Pharmaceuticals, Inc. eps - earnings per share from 2013 to 2018. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| OncoMed Pharmaceuticals, Inc. Annual EPS |
| 2018 |
$-0.21 |
| 2017 |
$-1.04 |
| 2016 |
$-3.14 |
| 2015 |
$-2.84 |
| 2014 |
$-1.69 |
| 2013 |
$-1.93 |
| 2012 |
$-21.30 |
| 2011 |
$-15.40 |
| 2010 |
$-30.47 |
| OncoMed Pharmaceuticals, Inc. Quarterly EPS |
| 2018-12-31 |
$-0.12 |
| 2018-09-30 |
$0.16 |
| 2018-06-30 |
$-0.10 |
| 2018-03-31 |
$-0.15 |
| 2017-12-31 |
$0.25 |
| 2017-09-30 |
$-0.28 |
| 2017-06-30 |
$-0.40 |
| 2017-03-31 |
$-0.61 |
| 2016-12-31 |
$-0.56 |
| 2016-09-30 |
$-0.77 |
| 2016-06-30 |
$-0.91 |
| 2016-03-31 |
$-0.90 |
| 2015-12-31 |
$-0.82 |
| 2015-09-30 |
$-0.81 |
| 2015-06-30 |
$-0.72 |
| 2015-03-31 |
$-0.49 |
| 2014-12-31 |
$-0.51 |
| 2014-09-30 |
$-0.18 |
| 2014-06-30 |
$-0.53 |
| 2014-03-31 |
$-0.47 |
| 2013-12-31 |
$14.97 |
| 2013-09-30 |
$-0.15 |
| 2013-06-30 |
$-8.83 |
| 2013-03-31 |
$-7.92 |
| 2012-09-30 |
$-3.45 |
| 2012-06-30 |
$-3.64 |
